Methodology: IHC

Clinical Significance:
Identifies: A nuclear transcription factor that is expressed in a very high percentage of lung and thyroid carcinomas. In lung carcinomas, it is expressed in both non-neuroendocrine as well as endocrine neoplasms, but only rarely in lung squamous cell carcinomas. It is expressed in all variants of thyroid carcinoma with the exception of anaplastic carcinoma. TTF1 loses its organ specificity in the context of high grade neuroendocrine carcinomas. It can also more uncommonly be expressed in other carcinomas, including those primary to the colorectum and breast. Subcellular Localization: Nuclear

Organ: Lung

Disease State: Carcinomas of Unknown Primary

CPT Code(s): 88342 or 88341. The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Turnaround Time: Within 1-2 business days of receipt

Schedule: Monday - Friday

Specimen Requirements:
• Formalin-fixed, paraffin-embedded (FFPE) tissue block or cell block - OR - • 1 unstained slide for each test requested plus 3-4 additional unstained slides cut at 4µm